AGNC Investment (AGNC - Free Report) closed at $10.94 in the latest trading session, marking a -1.62% move from the prior day. This change lagged the S&P 500's 0.28% loss on the day. Elsewhere, the Dow saw a downswing of 1.09%, while the tech-heavy Nasdaq appreciated by 0.2%.
The real estate investment trust's stock has climbed by 7.86% in the past month, exceeding the Finance sector's gain of 5.35% and the S&P 500's gain of 1.64%.
Analysts and investors alike will be keeping a close eye on the performance of AGNC Investment in its upcoming earnings disclosure. The company's earnings report is set to go public on July 20, 2026. The company is forecasted to report an EPS of $0.38, showcasing no movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $361.52 million, indicating a 123.16% upward movement from the same quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $1.56 per share and a revenue of $1.47 billion, indicating changes of +4% and +117.14%, respectively, from the former year.
Investors should also pay attention to any latest changes in analyst estimates for AGNC Investment. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. AGNC Investment is holding a Zacks Rank of #3 (Hold) right now.
Looking at its valuation, AGNC Investment is holding a Forward P/E ratio of 7.12. Its industry sports an average Forward P/E of 8.95, so one might conclude that AGNC Investment is trading at a discount comparatively.
The REIT and Equity Trust industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 209, placing it within the bottom 16% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow AGNC in the coming trading sessions, be sure to utilize Zacks.com.
Chubb (CB - Free Report) closed at $355.09 in the latest trading session, marking a -1.17% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.28%. On the other hand, the Dow registered a loss of 1.09%, and the technology-centric Nasdaq increased by 0.2%.
Coming into today, shares of the insurer had gained 10.51% in the past month. In that same time, the Finance sector gained 5.35%, while the S&P 500 gained 1.64%.
Market participants will be closely following the financial results of Chubb in its upcoming release. The company plans to announce its earnings on July 21, 2026. The company is expected to report EPS of $6.58, up 7.17% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $15.89 billion, showing a 7.26% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $26.77 per share and revenue of $64.36 billion, which would represent changes of +7.99% and +7.33%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Chubb. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.11% lower. Chubb is currently a Zacks Rank #3 (Hold).
In the context of valuation, Chubb is at present trading with a Forward P/E ratio of 13.42. This indicates a premium in contrast to its industry's Forward P/E of 12.17.
We can additionally observe that CB currently boasts a PEG ratio of 1.84. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The average PEG ratio for the Insurance - Property and Casualty industry stood at 2.56 at the close of the market yesterday.
The Insurance - Property and Casualty industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 112, finds itself in the top 46% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Southern Copper (SCCO - Free Report) closed the most recent trading day at $167.21, moving -1.5% from the previous trading session. This change lagged the S&P 500's 0.28% loss on the day. Elsewhere, the Dow lost 1.09%, while the tech-heavy Nasdaq added 0.2%.
Heading into today, shares of the miner had lost 3.09% over the past month, lagging the Basic Materials sector's loss of 3.01% and the S&P 500's gain of 1.64%.
Analysts and investors alike will be keeping a close eye on the performance of Southern Copper in its upcoming earnings disclosure. In that report, analysts expect Southern Copper to post earnings of $1.9 per share. This would mark year-over-year growth of 55.74%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.26 billion, up 39.64% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $7.62 per share and revenue of $16.69 billion, indicating changes of +45.42% and +24.4%, respectively, compared to the previous year.
Investors should also note any recent changes to analyst estimates for Southern Copper. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 5% higher. As of now, Southern Copper holds a Zacks Rank of #3 (Hold).
Investors should also note Southern Copper's current valuation metrics, including its Forward P/E ratio of 22.29. This denotes a discount relative to the industry average Forward P/E of 22.58.
It is also worth noting that SCCO currently has a PEG ratio of 1.52. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Mining - Non Ferrous industry currently had an average PEG ratio of 1.29 as of yesterday's close.
The Mining - Non Ferrous industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 169, positioning it in the bottom 32% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
CrowdStrike Holdings (CRWD - Free Report) closed at $191.24 in the latest trading session, marking a -1.74% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.28% for the day. Elsewhere, the Dow lost 1.09%, while the tech-heavy Nasdaq added 0.2%.
The stock of cloud-based security company has risen by 20.71% in the past month, leading the Computer and Technology sector's loss of 1.22% and the S&P 500's gain of 1.64%.
Analysts and investors alike will be keeping a close eye on the performance of CrowdStrike Holdings in its upcoming earnings disclosure. The company is expected to report EPS of $0.29, up 26.09% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $1.44 billion, indicating a 23.19% increase compared to the same quarter of the previous year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $1.23 per share and revenue of $5.94 billion, indicating changes of +32.26% and +23.49%, respectively, compared to the previous year.
Investors should also pay attention to any latest changes in analyst estimates for CrowdStrike Holdings. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 1.34% increase. At present, CrowdStrike Holdings boasts a Zacks Rank of #4 (Sell).
In the context of valuation, CrowdStrike Holdings is at present trading with a Forward P/E ratio of 157.78. Its industry sports an average Forward P/E of 50.32, so one might conclude that CrowdStrike Holdings is trading at a premium comparatively.
Investors should also note that CRWD has a PEG ratio of 5.69 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Security stocks are, on average, holding a PEG ratio of 3.31 based on yesterday's closing prices.
The Security industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 169, putting it in the bottom 32% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
In the latest trading session, Coupang, Inc. (CPNG - Free Report) closed at $19.00, marking a +2.54% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.28%. Elsewhere, the Dow saw a downswing of 1.09%, while the tech-heavy Nasdaq appreciated by 0.2%.
Coming into today, shares of the company had gained 16.47% in the past month. In that same time, the Retail-Wholesale sector gained 0.18%, while the S&P 500 gained 1.64%.
Analysts and investors alike will be keeping a close eye on the performance of Coupang, Inc. in its upcoming earnings disclosure. On that day, Coupang, Inc. is projected to report earnings of -$0.26 per share, which would represent a year-over-year decline of 1400%. Alongside, our most recent consensus estimate is anticipating revenue of $8.86 billion, indicating a 3.97% upward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$0.33 per share and a revenue of $37.65 billion, signifying shifts of -375% and +9.01%, respectively, from the last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Coupang, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been a 94.12% fall in the Zacks Consensus EPS estimate. Coupang, Inc. presently features a Zacks Rank of #4 (Sell).
The Internet - Commerce industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 181, which puts it in the bottom 27% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Cloudflare (NET - Free Report) closed the most recent trading day at $273.40, moving +1.7% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.28%. On the other hand, the Dow registered a loss of 1.09%, and the technology-centric Nasdaq increased by 0.2%.
The web security and content delivery company's shares have seen an increase of 13.85% over the last month, surpassing the Computer and Technology sector's loss of 1.22% and the S&P 500's gain of 1.64%.
The upcoming earnings release of Cloudflare will be of great interest to investors. It is anticipated that the company will report an EPS of $0.27, marking a 28.57% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $665.42 million, indicating a 29.88% growth compared to the corresponding quarter of the prior year.
NET's full-year Zacks Consensus Estimates are calling for earnings of $1.2 per share and revenue of $2.81 billion. These results would represent year-over-year changes of +29.03% and +29.72%, respectively.
Investors might also notice recent changes to analyst estimates for Cloudflare. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. The Zacks Consensus EPS estimate has moved 283.33% higher within the past month. Cloudflare is currently sporting a Zacks Rank of #2 (Buy).
Looking at its valuation, Cloudflare is holding a Forward P/E ratio of 223.52. This expresses a premium compared to the average Forward P/E of 19.93 of its industry.
Investors should also note that NET has a PEG ratio of 5.18 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Internet - Software industry had an average PEG ratio of 1.1 as trading concluded yesterday.
The Internet - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 95, putting it in the top 39% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
In the latest trading session, Devon Energy (DVN - Free Report) closed at $43.31, marking a +2.12% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 0.28% for the day. Meanwhile, the Dow experienced a drop of 1.09%, and the technology-dominated Nasdaq saw an increase of 0.2%.
Shares of the oil and gas exploration company witnessed a loss of 3.77% over the previous month, beating the performance of the Oils-Energy sector with its loss of 4.3%, and underperforming the S&P 500's gain of 1.64%.
The investment community will be closely monitoring the performance of Devon Energy in its forthcoming earnings report. The company is scheduled to release its earnings on August 4, 2026. On that day, Devon Energy is projected to report earnings of $1.3 per share, which would represent year-over-year growth of 54.76%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $6.25 billion, up 45.85% from the year-ago period.
DVN's full-year Zacks Consensus Estimates are calling for earnings of $4.81 per share and revenue of $24.59 billion. These results would represent year-over-year changes of +22.7% and +43.09%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Devon Energy. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 12.9% rise in the Zacks Consensus EPS estimate. At present, Devon Energy boasts a Zacks Rank of #3 (Hold).
In terms of valuation, Devon Energy is presently being traded at a Forward P/E ratio of 8.82. This indicates a discount in contrast to its industry's Forward P/E of 9.28.
The Oil and Gas - Exploration and Production - United States industry is part of the Oils-Energy sector. This industry, currently bearing a Zacks Industry Rank of 177, finds itself in the bottom 29% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow DVN in the coming trading sessions, be sure to utilize Zacks.com.
Upstart Holdings, Inc. (UPST - Free Report) ended the recent trading session at $31.81, demonstrating a -3.78% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.28%. Meanwhile, the Dow experienced a drop of 1.09%, and the technology-dominated Nasdaq saw an increase of 0.2%.
Shares of the company have appreciated by 6.44% over the course of the past month, outperforming the Finance sector's gain of 5.35%, and the S&P 500's gain of 1.64%.
The investment community will be paying close attention to the earnings performance of Upstart Holdings, Inc. in its upcoming release. The company is slated to reveal its earnings on August 4, 2026. The company is predicted to post an EPS of $0.55, indicating a 52.78% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $354.89 million, up 37.93% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $2.27 per share and a revenue of $1.43 billion, representing changes of +30.46% and +36.53%, respectively, from the prior year.
Any recent changes to analyst estimates for Upstart Holdings, Inc. should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Upstart Holdings, Inc. is holding a Zacks Rank of #3 (Hold) right now.
Investors should also note Upstart Holdings, Inc.'s current valuation metrics, including its Forward P/E ratio of 14.59. This indicates a premium in contrast to its industry's Forward P/E of 11.09.
It's also important to note that UPST currently trades at a PEG ratio of 0.35. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Financial - Miscellaneous Services industry stood at 1.01 at the close of the market yesterday.
The Financial - Miscellaneous Services industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 155, positioning it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Flutter's logo is pictured on a smartphone in this illustration taken, December 4, 2021. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
CompaniesJuly 8 (Reuters) - Michael Burry, the investor famed for predicting and profiting from the 2008 U.S. housing market collapse, has bought shares of sports-betting platforms Flutter Entertainment (FLTRF.L), opens new tab and DraftKings (DKNG.O), opens new tab, wagering regulatory scrutiny will eventually curb the threat posed by prediction markets.
Burry said on Wednesday he bought Flutter at about $107 a share and DraftKings "in the low $26s." Together, the investments make up a full-sized position weighted roughly 60/40 toward Flutter, though the investor said he may make each a full position in the future.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Prediction markets are the main threat facing the two companies, Burry said in a post on his website, because their event contracts can be offered nationwide under Commodity Futures Trading Commission oversight while avoiding state gaming taxes.
Prediction markets let traders buy and sell contracts tied to the outcome of events, including sports, elections and economic data.
Burry said these platforms operate in a loophole alongside a heavily regulated and taxed gambling industry. "I believe that the political climate will not tolerate this," he wrote, adding that he expects prediction markets to eventually be brought under regulation and taxation.
Shares of Flutter, down 50% this year as of last close, remain attractive because the company is a strong business with significant scale despite past capital misallocation, while DraftKings, whose shares are down 21%, is inflecting as an operating business, the investor said.
Meanwhile, Burry also said he bought more JD.com shares at $27.58, calling it one of his top three positions, and that he expects Hong Kong and Chinese stocks to benefit as AI and memory-chip enthusiasm unwinds in South Korea and Japan.
Reporting by Pragyan Kalita in Bengaluru; Editing by Jonathan Ananda
Our Standards: The Thomson Reuters Trust Principles., opens new tab
DKNG stock is up. See the chart and price action here. Burry Bets on Sportsbooks"DraftKings is inflecting as an operating business and the value is in the transition I foresee in the near future," he wrote, per CNBC. "Flutter has been hurt by capital misallocation in the past, but is a fundamentally very good operating business with terrific scale."
Burry’s comments highlight a focus on cash generation and scale rather than top-line growth in a crowded U.S. market.
Context: Flutter’s Missteps and DraftKings’ PivotFlutter faced investor skepticism due to uneven U.S. growth and capital deployment that pressured margins. Burry’s view suggests those issues are largely behind it. Its global footprint and the FanDuel brand may provide leverage as capital allocation improves.
DraftKings spent aggressively on customer acquisition, but now emphasizes profitability and disciplined promotions. Burry’s "inflecting" language signals a shift from land-grab strategy toward sustainable earnings as the market consolidates.
Bearish on Prediction MarketsDespite backing regulated sportsbooks, Burry is skeptical of prediction markets, platforms such as Kalshi and Polymarket that allow trading on outcomes such as elections and macro data. "I believe that the political climate will not tolerate this," Burry said, per CNBC.
"Prediction markets exist in a loophole adjacent to a heavily regulated and taxed industry. In time, prediction markets will be subsumed into regulation and taxation."
Regulators are moving in that direction. The U.S. Commodity Futures Trading Commission has proposed rules to bring parts of the sector under derivatives oversight. Legal experts also cite concerns around manipulation and insider trading, especially on offshore crypto-native platforms.
DKNG, FLUT Stock Price Activity: DraftKings stock was up 0.99% at $27.44 and Flutter Entertainment shares were up 0.51% at $111.89 during after-hours trading on Wednesday, according to data from Benzinga Pro.
Photo: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Zoetis class action, go to https://rosenlegal.com/cases/zoetis-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and touted growing market share, strong veterinarian adoption, and accelerating sales growth across Zoetis' flagship Companion Animal products and/or failed to disclose that: (1) veterinarian prescription growth and adoption of Zoetis' Librela, a canine pain treatment, were sharply weakening as clinicians became more cautious following FDA safety warnings concerning serious neurological complications in dogs; (2) Zoetis' Simparica Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; and (3) Zoetis' dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Zoetis class action, go to https://rosenlegal.com/cases/zoetis-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304471
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
In the latest close session, ZIM Integrated Shipping Services (ZIM - Free Report) was up +2.84% at $24.60. The stock exceeded the S&P 500, which registered a loss of 0.28% for the day. On the other hand, the Dow registered a loss of 1.09%, and the technology-centric Nasdaq increased by 0.2%.
The container shipping company's stock has dropped by 6.2% in the past month, falling short of the Transportation sector's gain of 1.18% and the S&P 500's gain of 1.64%.
The investment community will be closely monitoring the performance of ZIM Integrated Shipping Services in its forthcoming earnings report. The company is expected to report EPS of -$0.1, down 152.63% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.63 billion, down 0.58% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $3.15 per share and a revenue of $7.05 billion, signifying shifts of +2.27% and +2.09%, respectively, from the last year.
It is also important to note the recent changes to analyst estimates for ZIM Integrated Shipping Services. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 143.51% higher. ZIM Integrated Shipping Services is holding a Zacks Rank of #1 (Strong Buy) right now.
Digging into valuation, ZIM Integrated Shipping Services currently has a Forward P/E ratio of 7.59. This represents a discount compared to its industry average Forward P/E of 8.47.
The Transportation - Shipping industry is part of the Transportation sector. At present, this industry carries a Zacks Industry Rank of 41, placing it within the top 17% of over 250 industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Item 1 of 3 The Warner Bros. Water Tower is pictured at Warner Bros. Studios in Burbank, California, U.S. February 27, 2026. REUTERS/Daniel Cole/File Photo
[1/3]The Warner Bros. Water Tower is pictured at Warner Bros. Studios in Burbank, California, U.S. February 27, 2026. REUTERS/Daniel Cole/File Photo Purchase Licensing Rights, opens new tab
CompaniesJuly 8 (Reuters) - Paramount has said it will not close its $110 billion acquisition of Warner Bros before July 22, the Oregon attorney general's office said, pushing out the timeline for the deal's closure by an additional week.
Oregon Attorney General Dan Rayfield's office is asking a court in Multnomah County on Wednesday to order the company to hand over records and delay the deal by 60 days so the state can review them.
The Reuters Inside Track newsletter is your essential guide during the World Cup. Sign up here.
Paramount had previously told Oregon that it would not close the deal before July 16, Rayfield's office said. At a preliminary hearing on the state's request on Wednesday, the company amended that timeline, his office said.
Reporting by Jody Godoy; Editing by Nia Williams and Edmund Klamann
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Jody Godoy reports on tech policy and antitrust enforcement, including how regulators are responding to the rise of AI. Reach her at [email protected]
U.S. states concerned that Paramount's $110 billion acquisition of Warner Bros. Discovery will hurt competition could sue to block the deal as soon as next week, two sources familiar with the matter told Reuters.
July 08, 2026 17:49 ET | Source: Mercator Acquisition Corp.
NORWALK, CT , July 08, 2026 (GLOBE NEWSWIRE) -- Mercator Acquisition Corp. (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today that it has priced its initial public offering of 15,000,000 units at $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, July 9, 2026, under the ticker symbol “MRCOU." Each whole warrant is exercisable to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq under the symbols “MRCO” and “MRCOW,” respectively.
Clear Street is acting as sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 units at the initial public offering price to cover over-allotments, if any.
The Company intends to focus on technology and software infrastructure companies whose products and services target financial services, real estate and asset management companies. The Company is led by Shawn Matthews, Chairman and Chief Executive Officer; Steve Bischoff, Chief Financial Officer, and Shawn Matthews Jr., President.
The public offering is being made only by means of a prospectus. When available, copies of the prospectus relating to the offering may be obtained from: Clear Street LLC, 4 World Trade Center, 150 Greenwich St., Floor 45, New York, NY 10007, or by e-mail at [email protected].
A registration statement relating to the securities was filed with, and declared effective by, the Securities and Exchange Commission (“SEC”) on July 8, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company's registration statement filed with the SEC and the preliminary prospectus included therein. Copies of these documents are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
About Mercator Acquisition Corp.
Mercator Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on technology and software infrastructure companies whose products and services target financial services, real estate and asset management companies.
In a recent interview, legendary investor Bill Ackman was asked about why he was bullish on the economy of Israel. The question comes with Ackman owning around a 5% stake in the Tel Aviv Stock Exchange.
• Teva Pharmaceutical stock is trading at elevated levels. Where are TEVA shares going?
Ackman on Israel’s Opportunity"I’m very bullish on Israel from an economic perspective," Ackman said. "Imagine if Silicon Valley was a country."
Ackman highlighted the density of talent and IP in the small country and entrepreneurs who have been through a pretty brutal war, who have now developed "grit."
The region is seeing top venture capital firms opening offices and companies turning down small offers from large tech companies to grow on their own.
"You’re gonna see a trillion dollar company come out of Israel in the not-too-distant future."
Ackman said the company will likely be in the cybersecurity or AI sectors.
"It’s one of the best economies in the world."
Top Israeli CompaniesInvestors looking for exposure to Israel can invest in the iShares MSCI Israel ETF (NYSE:EIS), which has stakes in companies that are public in the U.S. and some in Israel, with all having headquarters in Israel.
Here are the current top 10 holdings of the ETF:
Of the top 10 holdings in the ETF, six can be bought on major U.S. exchanges.
In 2024, Ackman and his wife, Neri Oxman, invested in the Tel Aviv Stock Exchange, with a 5% stake worth around $25 million. The investor could benefit if more people invest in companies headquartered in Israel, meaning his comments should be taken with some caution.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
In the latest trading session, Zscaler (ZS - Free Report) closed at $143.55, marking a -3.98% move from the previous day. This change lagged the S&P 500's 0.28% loss on the day. Elsewhere, the Dow lost 1.09%, while the tech-heavy Nasdaq added 0.2%.
The stock of cloud-based information security provider has risen by 18.8% in the past month, leading the Computer and Technology sector's loss of 1.22% and the S&P 500's gain of 1.64%.
Analysts and investors alike will be keeping a close eye on the performance of Zscaler in its upcoming earnings disclosure. The company is forecasted to report an EPS of $1.09, showcasing a 22.47% upward movement from the corresponding quarter of the prior year. In the meantime, our current consensus estimate forecasts the revenue to be $877.19 million, indicating a 21.96% growth compared to the corresponding quarter of the prior year.
ZS's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $3.33 billion. These results would represent year-over-year changes of +26.22% and +24.57%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Zscaler. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 9.1% higher within the past month. At present, Zscaler boasts a Zacks Rank of #3 (Hold).
Looking at its valuation, Zscaler is holding a Forward P/E ratio of 36.14. For comparison, its industry has an average Forward P/E of 50.32, which means Zscaler is trading at a discount to the group.
It is also worth noting that ZS currently has a PEG ratio of 2.47. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. ZS's industry had an average PEG ratio of 3.31 as of yesterday's close.
The Security industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 169, this industry ranks in the bottom 32% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Veeva Systems (VEEV - Free Report) closed at $188.17 in the latest trading session, marking a -2.15% move from the prior day. This move lagged the S&P 500's daily loss of 0.28%. At the same time, the Dow lost 1.09%, and the tech-heavy Nasdaq gained 0.2%.
Heading into today, shares of the provider of cloud-based software services for the life sciences industry had gained 14.68% over the past month, outpacing the Medical sector's gain of 7.8% and the S&P 500's gain of 1.64%.
The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company's upcoming EPS is projected at $2.22, signifying a 11.56% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $904.07 million, up 14.57% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $9.05 per share and revenue of $3.64 billion, indicating changes of +11.73% and +13.96%, respectively, compared to the previous year.
Investors should also note any recent changes to analyst estimates for Veeva Systems. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Veeva Systems is holding a Zacks Rank of #3 (Hold) right now.
Investors should also note Veeva Systems's current valuation metrics, including its Forward P/E ratio of 21.26. This expresses a discount compared to the average Forward P/E of 27.43 of its industry.
It's also important to note that VEEV currently trades at a PEG ratio of 0.61. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. By the end of yesterday's trading, the Medical Info Systems industry had an average PEG ratio of 3.2.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 160, putting it in the bottom 35% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
CROX weekly chart shows bounce within a large symmetrical triangle formation and higher targets. Source: TradingVIew The bearish correction from the June high retraced to a low of $117.49, almost reaching the 38.2% Fibonacci level of $116.37. If that minimum Fibonacci retracement level is maintained, it would be a sign of relative strength when compared to the retracement of the prior upswing, which completed an approximate 50% retracement. This shows improving underlying demand, since buyers did not wait for a deeper pullback before stepping in.
Breakout Trigger Comes into Focus If the pennant is to retain its integrity, signs of support followed by renewed buying pressure should be seen once the lower boundary of the formation is tested. It looks like that could happen soon, since CROX fell to an eight-day low of $119.74, showing short-term weakness within the developing consolidation pattern. Given its current configuration, an upside breakout would trigger above the lower swing high of $128.64 from Tuesday.
Measured Move Points Toward Higher Target Based on a sharp approximately 32% rise that preceded the pennant consolidation, which identifies the pole portion of the pattern, a successful breakout of the pattern suggests an estimated target of at least $159.68. The pole measurement begins from the momentum breakout that followed the May swing low. Although that target only uses a measured move from the pennant formation, it also aligns near a significant lower swing high of $165.32.
Pattern Support Defines Risk In addition to the support levels mentioned above, the higher swing low of $117.49 helps define pennant support. If it is broken to the downside, the pennant pattern is invalidated. Therefore, the reaction near the lower boundary will be important, as a successful defense would reinforce the bullish continuation setup while a breakdown would signal that the consolidation pattern has failed.
If you’d like to know more about technical analysis and how traders use it, please visit our educational area.
MINNEAPOLIS--(BUSINESS WIRE)--On Thursday, July 30, 2026, Xcel Energy (NASDAQ: XEL) will host a conference call to review second quarter 2026 financial results. The earnings report will be released prior to the market open on the same date.The call will begin at 9:00 a.m. Central Time. To participate in the conference call, please dial in at least 10 minutes prior to the scheduled start and follow the operator's instructions.U.S. Toll-Free Dial-In: 1-800-715-9871U.S. / International Toll Dial-In.
Berkshire Hathaway B (BRK.B - Free Report) closed at $494.79 in the latest trading session, marking a -1.83% move from the prior day. This move lagged the S&P 500's daily loss of 0.28%. Meanwhile, the Dow experienced a drop of 1.09%, and the technology-dominated Nasdaq saw an increase of 0.2%.
The company's stock has climbed by 3.33% in the past month, falling short of the Finance sector's gain of 5.35% and outpacing the S&P 500's gain of 1.64%.
Market participants will be closely following the financial results of Berkshire Hathaway B in its upcoming release. The company's upcoming EPS is projected at $5.53, signifying a 6.96% increase compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $95.3 billion, indicating a 3.01% growth compared to the corresponding quarter of the prior year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $20.82 per share and a revenue of $385.6 billion, signifying shifts of +0.97% and +3.81%, respectively, from the last year.
It is also important to note the recent changes to analyst estimates for Berkshire Hathaway B. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. At present, Berkshire Hathaway B boasts a Zacks Rank of #2 (Buy).
In terms of valuation, Berkshire Hathaway B is currently trading at a Forward P/E ratio of 24.21. For comparison, its industry has an average Forward P/E of 12.17, which means Berkshire Hathaway B is trading at a premium to the group.
The Insurance - Property and Casualty industry is part of the Finance sector. With its current Zacks Industry Rank of 112, this industry ranks in the top 46% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
CHARLOTTE, N.C., July 08, 2026 (GLOBE NEWSWIRE) -- SPX Technologies, Inc. (NYSE:SPXC) announced today that it will release its financial results for the second quarter of fiscal year 2026 after the U.S. financial markets close on Thursday, July 30, 2026.
In conjunction with this announcement, SPX Technologies’ President and Chief Executive Officer Gene Lowe and SPX Technologies’ Vice President, Chief Financial Officer Mark Carano will discuss the Company’s financial results and business outlook during a conference call on Thursday, July 30, 2026, at 4:45 p.m. Eastern Time.
Webcast and slides:
The call will be simultaneously webcast and the slides will be available in the Investor Relations section of the company’s website at https://www.spx.com/investor-relations/webcasts-and-presentations, or through the following link: https://edge.media-server.com/mmc/p/o5op5ou8.
Call access:
To access the call by phone, please use the following link to receive dial-in details https://register-conf.media-server.com/register/BI1493b55e6e4e4d7eb65b63476990f468. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at www.spx.com.
About SPX Technologies, Inc: SPX Technologies, Inc. is a diversified, global supplier of highly engineered products and technologies, holding leadership positions in the HVAC and detection and measurement markets. Based in Charlotte, North Carolina, SPX Technologies, Inc. has operations in over 16 countries. SPX Technologies, Inc. is listed on the New York Stock Exchange under the ticker symbol “SPXC.” For more information, please visit www.spx.com.
(Kitco News) – While Q2 was the worst quarter for gold in 12 years, with spiking energy prices raising inflation expectations and introducing the possibility of rate hikes, central bank demand will help gold finish the year on a positive note, according to the new quarterly gold outlook from Invesco.
“The gold price fell by 14.1% in Q2, more than erasing its gains from Q1 and leaving it over $1,500 an ounce off the all-time intraday high set in late-January this year,” wrote Sam Whitehead, Head of Alternative and ESG ETF Product Strategy, Benjamin Jones, Global Head of Research, and David Scales, Senior ETF Investment Editor. “Volatility picked up in April, but most of the decline in the gold price occurred over the following two months. On 24 June, the yellow metal dipped just below $4,000 an ounce for the first time since November 2025. Gold spent the following days bouncing around that psychologically relevant level and ended the quarter at $4,008.”
The authors said this constituted the worst quarter for gold since Q2 2013, when the price fell by 22.7%, but pointed out that these kinds of pullbacks “are not uncommon when any market has risen so strongly for a sustained period, and this latest price correction might prove healthy given gold is still up by 21.3% over the past 12 months.”
They warned, however, that downside risks to the gold price remain. “The next few months could be pivotal for gold, as we watch to see how the Fed reacts to inflation – and whether inflation is sticky or comes down with lower oil prices – and if the US Dollar firms further versus other major currencies,” they said. “Higher interest rates and a stronger USD are generally negative for gold, as the former increases the opportunity cost of holding a non-yielding asset and the latter makes gold more expensive for international (non-US) investors.”
The authors wrote that several headwinds drove the gold price lower during the quarter. “Inflation emerged as a threat that could potentially linger beyond what was previously being priced in, which means interest rates could stay higher for longer,” they said. “The US Dollar strengthened, though only a little, partly in reply to the revised interest rate outlook and, lastly, some of the geopolitical risk premia was removed from the perceived ‘haven’ asset as the market seemed convinced that negotiations between the US and Iran were progressing towards a satisfactory outcome.”
They noted that the conflict’s impact on energy prices resulted in a market focused on inflation. “The longer the conflict continues, the more lasting the impact on inflation not just on oil prices but knock-on effects more broadly,” they said. “WTI Crude ended the quarter at $70/barrel, an indication the market expects supply to resume.”
The authors said easing inflation expectations indicate that the broader market believes the recent inflation will be brought under control. “The question is whether the market is being overly optimistic, given recent actual inflation readings and with the US-Iran situation still potentially volatile.”
They pointed out that PCE inflation hit 4.1% in May, the highest level since April 2023, driven mainly by elevated energy prices, but core PCE, which excludes food and energy, also reached 3.4%, the highest reading since October 2023. “The FOMC, under new Fed Chair Kevin Warsh, had sounded a warning to the market in the minutes following the committee’s April meeting, saying it would “deliver price stability” after inflation has remained above the target 2% rate for five years running.”
The Invesco analysts said the recent gold price correction could be seen as a reasonable response “to the rise in inflation expectations, the Fed’s more hawkish view on interest rates and the recent strength in the US Dollar.”
“The USD eased at the beginning of the quarter but spent most of the period gaining against its major trading partners,” they said. “A stronger USD makes gold more expensive for international (non-US) investors and consumers, which tends to reduce demand from those important segments.”
The authors noted that after a general expectation of further rate cuts, interest rates are now forecast to rise in 2026.
“Earlier this year, the futures market had been predicting Fed rate cuts in 2026, with the only question being how many,” they said. “The CME FedWatch tool was showing practically no chance of a rate hike this year. The inflation pressures mentioned above then shifted the market’s expectations, with the Fed under new Chair Warsh seemingly more committed to addressing the persistence of above-target inflation, with hikes firmly on the table.”
By the end of May the market was pricing in virtually no chance of a cut in 2026, and began entertaining the possibility of rate hikes.
“When the quarter ended, the market was placing a 33.7% probability of a 25 basis-point increase at the end of July and at least one rate hike (67% chance) by the time the FOMC concludes its September meeting,” they wrote. “The CME FedWatch shows an 83% probability that interest rates will be higher than they are now by the end of the year. Higher interest rates are negative for gold, as it increases the opportunity cost of holding the non-yielding gold asset.”
But despite the rise in inflation expectations, the potential for rate hikes, and the yellow metal’s recent weakness, Invesco maintains a constructive outlook for gold in the second half of 2026.
“[W]e believe much of the structural support for gold remains largely intact,” the authors said. “Central banks look set to continue buying gold to diversify their reserves. The World Gold Council (WGC) reported that a record 45% of central bankers responding to its latest survey said they expected to increase their gold reserves in the next 12 months, while 89% expect gold central bank reserves to increase globally over the coming year.”
They noted that this structural support was reflected in their recent Global Sovereign Asset Management Study, “in which a majority of central banks reported increasing gold allocations over the past three years, with concern over global volatility, inflation protection, and geopolitical uncertainty now among the leading drivers of ongoing gold purchases.”
But while central bank demand is largely price-insensitive, they said, investment demand is sensitive to price momentum. “Rising prices may attract flows into an asset, but falling prices can sometimes encourage selling, particularly when an investor can lock in a profit and needs to access liquidity to reallocate elsewhere,” the authors wrote. “Retail purchases of coins and small gold bars were a strong source of demand throughout the long-term gold rally, and it will be important to see how they respond to the correction.”
“For retail and professional investors, the case for including gold in a portfolio is not based on a single consideration, such as using it only to hedge geopolitical risk, although historically gold has performed this role relatively well,” the Invesco analysts concluded. “Rather, gold can be a useful diversifier as it tends to have low correlation to most assets, especially equities. Gold is a unique asset as it has no issuer, no credit risk, and a long history as a store of value when confidence in currencies, institutions, or market plumbing is questioned.”
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.
Invesco Pharmaceuticals ETF has a higher 5-year growth total of $1,563 compared to $1,480 for First Trust NYSE Arca Biotechnology Index Fund First Trust NYSE Arca Biotechnology Index Fund is more affordable with a 0.55% expense ratio while Invesco Pharmaceuticals ETF charges 0.57% Invesco Pharmaceuticals ETF experienced a lower 5-year maximum drawdown of 17.50% compared to 29.90% for the First Trust fund
Recursion Pharmaceuticals (RXRX - Free Report) closed the most recent trading day at $3.72, moving -3.13% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.28%. On the other hand, the Dow registered a loss of 1.09%, and the technology-centric Nasdaq increased by 0.2%.
Coming into today, shares of the biotechnology company had gained 19.25% in the past month. In that same time, the Medical sector gained 7.8%, while the S&P 500 gained 1.64%.
The upcoming earnings release of Recursion Pharmaceuticals will be of great interest to investors. The company is forecasted to report an EPS of -$0.25, showcasing a 39.02% upward movement from the corresponding quarter of the prior year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $11.99 million, down 37.64% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.99 per share and revenue of $54.08 million. These totals would mark changes of +31.25% and -27.59%, respectively, from last year.
Any recent changes to analyst estimates for Recursion Pharmaceuticals should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. As of now, Recursion Pharmaceuticals holds a Zacks Rank of #2 (Buy).
The Medical - Biomedical and Genetics industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 110, placing it within the top 45% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow RXRX in the coming trading sessions, be sure to utilize Zacks.com.
SAN DIEGO, July 08, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hub Group, Inc. (NASDAQ: HUBG) securities between April 28, 2023 and May 11, 2026, both dates inclusive (the “Class Period”), have until August 28, 2026 to seek appointment as lead plaintiff of the Hub Group class action lawsuit. Captioned Lawler v. Hub Group, Inc., No. 26-cv-07596 (N.D. Ill.), the Hub Group class action lawsuit charges Hub Group and certain of Hub Group’s top current and former executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Hub Group class action lawsuit, please provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].
CASE ALLEGATIONS: Hub Group is a supply chain solutions provider that offers transportation and logistics management services.
The Hub Group class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Hub Group’s financial statements prepared for the periods from Q1 2023 to Q4 2024, including annual reports for 2023 and 2024, contained material misstatements caused by the premature and incorrect recognition of certain transactions concerning, among other things, Hub Group’s operating revenue, operating income, revenue recognition, effectiveness of internal controls and procedures, and drivers of financial results and growth; and (ii) Hub Group’s financial statements prepared for the periods from Q1 2025 to Q3 2025 contained material misstatements caused by the understatement of purchased transportation costs and accounts payable concerning, among other things, Hub Group’s operating expenses, purchased transportation and warehousing expenses, operating income, effectiveness of internal disclosure controls and procedures, and drivers of financial results and growth.
On February 5, 2026, Hub Group allegedly announced “that it will restate its financial statements for the first, second and third quarters of 2025” due to “an error that resulted in the understatement of purchased transportation costs and accounts payable in the first nine months of 2025.” Hub Group allegedly further announced that its reports for those quarters “were in each case materially misstated due to the aforementioned error and should no longer be relied upon” and that the “total amount of the reduction to accounts payable and purchased transportation costs related to this issue that was recorded during these periods is $77 million.” On this news, the price of Hub Group stock dropped approximately 18%, according to the complaint.
The Hub Group class action lawsuit further alleges that on May 12, 2026, Hub Group announced that it had “identified certain transactions that were prematurely or incorrectly recognized or not adequately supported,” rendering its 2023 and 2024 financial reports to be materially misstated such that they “should no longer be relied upon.” Hub Group allegedly further announced that it expected “to conclude that it did not maintain effective disclosure controls and procedures and internal control over financial reporting for each of the years ended December 31, 2024 and 2023.” On this news, the price of Hub Group stock fell 13%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Hub Group securities during the Class Period to seek appointment as lead plaintiff in the Hub Group class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Hub Group class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Hub Group class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Hub Group class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
Kevin Beth Allegedly Oversaw Hub Group's $77 Million Cost Understatement and Signed SOX Certifications Attesting to Financial Accuracy Before His Departure in May 2026
, /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hub Group, Inc. (NASDAQ: HUBG) that Kevin Beth, the Company's former Chief Financial Officer, is named as a defendant in a securities class action covering purchases between April 28, 2023, and May 11, 2026. Find out if you qualify to recover losses from the HUBG securities action. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
Hub Group shares fell a cumulative 51.33 to $36.62 following two corrective disclosures that revealed materially misstated financials spanning three years. The last day to move for lead plaintiff is August 28, 2026.
Kevin Beth's Tenure and Financial Oversight Responsibilities
Beth served as Hub Group's CFO, Executive Vice President, and Treasurer from January 1, 2024, until the announcement of his departure on May 28, 2026. Before becoming CFO, he served as the Company's Chief Accounting Officer and EVP, giving him direct involvement in Hub Group's financial reporting processes across a significant portion of the Class Period.
As CFO, Beth was responsible for the accuracy of Hub Group's financial disclosures, signed quarterly and annual SEC filings, and provided Sarbanes-Oxley certifications attesting that the Company's financial statements "fairly present in all material respects the financial condition, results of operations and cash flows" of Hub Group.
What Beth Allegedly Oversaw
The complaint identifies specific actions and statements attributed to Beth during his tenure as CFO:
Signed Hub Group's Forms 10-Q and 10-K filed with the SEC from Q1 2023 through Q3 2025 Provided SOX certifications for each filing period affirming that disclosure controls were effective and financial statements were materially accurate Stated on the Q1 2025 earnings call that purchased transportation costs decreased $82 million "due to strong cost controls as well as lower rail and warehouse expenses," when costs were allegedly understated by tens of millions Repeated similar cost reduction claims on Q2 and Q3 2025 earnings calls, each time attributing declines to operational efficiency rather than accounting errors Departed the Company on May 28, 2026, just sixteen days after the second corrective disclosure on May 12, 2026 rendered 2023 and 2024 annual reports unreliable Beth's SOX Certifications and Personal Liability
Under Sections 302 and 906 of the Sarbanes-Oxley Act, the certifying officer bears personal responsibility for the accuracy of financial statements filed with the SEC. The lawsuit contends that Beth certified financial statements he knew, or should have known, contained material misstatements regarding purchased transportation costs and accounts payable.
The action further asserts that Beth, as a controlling person under Section 20(a) of the Exchange Act, had the power to influence the content of Hub Group's SEC filings and public statements, and failed to ensure their accuracy.
"Individual officers who sign SEC certifications bear personal responsibility for the accuracy of corporate disclosures. When a company later admits those disclosures were materially misstated across multiple years, the certifying officers face serious questions about what they knew and when." -- Joseph E. Levi, Esq.
Speak with an attorney about Kevin Beth's alleged role in HUBG investor losses or call (212) 363-7500.
LEAD PLAINTIFF DEADLINE: August 28, 2026
ABOUT LEVI & KORSINSKY, LLP — Over the past 20 years, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report. Investors who suffered losses have until August 28, 2026 to seek appointment as lead plaintiff. Attorney Advertising. Prior results do not guarantee similar outcomes.
Frequently Asked Questions About the HUBG Lawsuit
Q: Who are the defendants named in the HUBG lawsuit? A: The complaint names Hub Group, Inc. and individual defendants including CEO Phillip Yeager, Executive Chairman David Yeager, former CFO Kevin Beth, former CFO Geoffrey DeMartino, CAO Dennis Mathews, and former CAO Brent Rhodes, all of whom signed SEC filings or made public statements during the Class Period.
Q: What specific misstatements does the HUBG lawsuit allege? A: The complaint alleges Hub Group materially misstated its financial results by understating purchased transportation costs and accounts payable, prematurely recognizing revenue, and falsely certifying that internal controls were effective, across filings from 2023 through the first three quarters of 2025.
Q: What if I already sold my HUBG shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: How do I know if I lost enough money to be the lead plaintiff? A: There is no minimum loss threshold. Courts appoint the investor with the largest provable loss who is willing and able to represent the class adequately. Contact Levi & Korsinsky before August 28, 2026 for an evaluation.
Q: What do HUBG investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible as a class member.
Q: Has Levi & Korsinsky handled similar cases before? A: Yes, including securities class actions involving revenue inflation, earnings guidance fraud, financial restatements, and executive misconduct across numerous industries.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cycle" While Manufacturing Issues at Its Acton Facility Allegedly Led to Medical Device Corrections Affecting Millions of Pods
, /PRNewswire/ -- Levi & Korsinsky, LLP examines the adequacy of Insulet Corporation's (NASDAQ: PODD) risk disclosures during the Class Period of February 21, 2025 through May 26, 2026. A securities class action has been filed alleging that Insulet's public filings contained materially misleading statements about manufacturing quality while defective controls at the Company's Acton, Massachusetts facility went undisclosed. Investors who lost money on PODD may find out if they qualify to recover losses from inadequate disclosures or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
Shares declined a cumulative 24.02 per share across two corrective disclosures, falling from 236.07 to $146.01, after the Company initiated Medical Device Corrections affecting millions of Omnipod insulin delivery devices. The lead plaintiff deadline is August 31, 2026.
What the Company Disclosed in SEC Filings
Insulet's FY 2024 and FY 2025 annual reports on Form 10-K contained nearly identical quality assurance language. Both filings stated that outside vendors "are audited periodically by our Quality team to confirm conformity with the specifications, policies, and procedures for our products" and that the Quality team "inspects and tests our products at various steps in the manufacturing cycle to facilitate compliance with our specifications."
Quarterly filings on Form 10-Q during the Class Period projected that gross margins would "increase compared with 2024 primarily due to improved manufacturing efficiencies."
What the Lawsuit Alleges Was Missing
The action contends that these quality assurance descriptions concealed specific, known deficiencies in Insulet's manufacturing controls at its Acton facility. The complaint charges that:
Cannula handling procedures at the Acton plant were defective, producing pods with small tears in internal tubing that could cause insulin to leak or under-deliver The Company's quality inspection process failed to detect these defects before distribution, despite claiming multi-step testing Risk factor language in SEC filings described general manufacturing risks without disclosing that specific, identified control failures were already producing defective units After the March 2026 recall, management claimed the issue was limited to "specific lots" and that unreleased pods were "very safe to use," when the same cannula tear defect would trigger a second, far larger recall two months later Why Generic Warnings Allegedly Failed to Protect Investors
The complaint challenges the gap between Insulet's specific public assurances and its generic risk factor language. Executives made concrete representations about manufacturing quality. On earnings calls, management stated the Company had "pioneered advanced automation" and could "deliver tens of millions of complex electromechanical devices per year at medical standards." The FY 2025 earnings call featured the claim that Insulet produces pods "with high-quality medical-grade quality at consumer electronic scale."
The lawsuit maintains that generic risk disclosures about potential manufacturing problems did not cure allegedly misleading affirmative statements about product quality and manufacturing controls. The May 2026 MDC revealed that approximately 7 million pods, representing 8.5% of 2025 global production, were affected by the same type of cannula tear defect.
"Generic risk factor language cannot substitute for disclosing specific, known problems that are already affecting a company's operations. When a company's SEC filings describe robust quality controls while manufacturing defects are producing millions of flawed medical devices, investors are denied the information they need to make informed decisions." -- Joseph E. Levi, Esq.
LEAD PLAINTIFF DEADLINE: August 31, 2026
Speak with an attorney about Insulet's disclosure failures or call (212) 363-7500.
Levi & Korsinsky, LLP — Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered. Attorney Advertising. Prior results do not guarantee similar outcomes.
Frequently Asked Questions About the PODD Lawsuit
Q: What specific misstatements does the PODD lawsuit allege? A: The complaint alleges Insulet made materially false or misleading statements regarding the quality and safety of its Omnipod manufacturing processes during the Class Period, while its Acton, Massachusetts facility was producing pods with defective cannula handling that caused insulin under-delivery. When two Medical Device Corrections revealed the scope of the problem, shares declined significantly.
Q: When did Insulet allegedly mislead investors? A: The class period runs from February 21, 2025 to May 26, 2026. During this time, SEC filings and executive statements allegedly presented a misleading picture of manufacturing quality. The truth emerged through corrective disclosures on March 12, 2026 and May 26, 2026.
Q: What is the PODD lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is August 31, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date.
Q: What if I already sold my PODD shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the class period and sold at a loss may still participate.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: What documents do I need to make a claim? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I missed the lead plaintiff deadline? A: The deadline applies only to investors seeking lead plaintiff appointment. Class members who miss it can still participate in any settlement or recovery.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
SAN DIEGO, July 08, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026. Insulet develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the U.S. and internationally.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
What is the class period? February 21, 2025 – May 26, 2026
What are the allegations? Robbins LLP is Investigating Allegations that Insulet Corporation (PODD) Misled Investors Regarding the Viability of its Products
According to the complaint, during the class period, defendants failed to disclose that: (i) Insulet’s manufacturing controls and procedures were defective; (ii) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
Plaintiff alleges that on March 12, 2026, Insulet disclosed that it had “initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue through its ongoing product monitoring” (the “March 2026 MDC”). On this news, Insulet’s stock price fell $16.23 per share, or 6.88%, to close at $219.84 per share on March 13, 2026. Then, on May 26, 2026, Insulet disclosed the “initat[ion]” of another “voluntary Medical Device Correction” (the “May 2026 MDC”), this time “for specific lots of Omnipod® 5, Omnipod Dash®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery.” On this news, Insulet’s stock price fell $7.79 per share, or 5.07%, to close at $146.01 per share on May 27, 2026.
What can shareholders do now? You may be eligible to participate in the class action against Insulet Corporation. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by August 31, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.
To be notified if a class action against Insulet Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the "Class Period"), of the important July 14, 2026 lead plaintiff deadline.
SO WHAT: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX's average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.
To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304456
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Shares of AppLovin (APP 1.00%) were moving lower last month, even after several positive analyst notes, as headwinds in the software sector weighed on the stock.
While AppLovin isn't a traditional software-as-a-service (SaaS) company, the stock has tracked with the sector this year as it trades at a high valuation, and some investors believe it faces AI disruption risks similar to those of the big cloud software companies.
As a result, AppLovin finished last month down 16%, according to data from S&P Global Market Intelligence. As you can see from the chart below, the stock trended with the iShares Expanded Tech-Software Sector ETF (IGV 1.75%), in which it's one of the top ten holdings.
APP data by YCharts
Investors sour on software again There was no major company-specific news out on AppLovin last month, but it couldn't escape the headwinds around the broader software sector.
Early in the month, disappointing earnings reports from companies like Salesforce, Adobe, and Oracle fed ongoing concerns about AI disruption, which may have been fueled by the fervor around the SpaceX IPO, and fears of rising interest rates following Kevin Warsh's first FOMC meeting also pressured the software sector lower.
As a high-growth stock, AppLovin is sensitive to interest rates, so it makes sense that it would pull back on signs that rates were going up, but it hasn't exhibited any AI-related slowdown, and it has a much different business model than SaaS leaders like Salesforce and Adobe.
Additionally, smaller rival Liftoff Mobile went public in early June, which could have prompted some selling in AppLovin as investors rotate to that stock or due to concerns that Liftoff will have more money to challenge AppLovin following the public offering.
Despite the sell-off, AppLovin received several Wall Street endorsements last month.
Citigroup opened an "upside 90-day catalyst watch" on the stock, and said the company could top estimates, driven by its e-commerce platform moving to general availability, though it removed the catalyst watch later in the month.
Edgewater Research upgraded the stock from neutral to outperform, and Raymond James initiated coverage with a strong buy and a price target of $640.
Image source: Getty Images.
AppLovin has been a volatile stock over the last year, more than doubling at one point before giving up nearly all of those gains.
It's trading at a high valuation, but it has the growth to back it up as analysts expect revenue to jump 54% in the second quarter to $1.94 billion and for earnings per share to increase from $2.39 to $3.75.
AppLovin is now trading at a forward P/E of just 33. If it can maintain its growth rate, the adtech stock should move higher.
Citigroup is an advertising partner of Motley Fool Money. Jeremy Bowman has positions in AppLovin. The Motley Fool has positions in and recommends Adobe, Oracle, and Salesforce. The Motley Fool recommends the following options: long January 2028 $330 calls on Adobe and short January 2028 $340 calls on Adobe. The Motley Fool has a disclosure policy.
In the latest trading session, Constellation Energy Corporation (CEG - Free Report) closed at $244.52, marking a +2.01% move from the previous day. This move outpaced the S&P 500's daily loss of 0.28%. At the same time, the Dow lost 1.09%, and the tech-heavy Nasdaq gained 0.2%.
Shares of the company have depreciated by 4.74% over the course of the past month, underperforming the Oils-Energy sector's loss of 4.3%, and the S&P 500's gain of 1.64%.
Investors will be eagerly watching for the performance of Constellation Energy Corporation in its upcoming earnings disclosure. The company is forecasted to report an EPS of $2.24, showcasing a 17.28% upward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $7.51 billion, reflecting a 23.16% rise from the equivalent quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $11.74 per share and a revenue of $35.48 billion, signifying shifts of +25.03% and +38.95%, respectively, from the last year.
Investors should also note any recent changes to analyst estimates for Constellation Energy Corporation. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.07% increase. Right now, Constellation Energy Corporation possesses a Zacks Rank of #3 (Hold).
In terms of valuation, Constellation Energy Corporation is presently being traded at a Forward P/E ratio of 20.42. Its industry sports an average Forward P/E of 17.86, so one might conclude that Constellation Energy Corporation is trading at a premium comparatively.
Investors should also note that CEG has a PEG ratio of 0.94 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Alternative Energy - Other industry held an average PEG ratio of 2.03.
The Alternative Energy - Other industry is part of the Oils-Energy sector. This group has a Zacks Industry Rank of 100, putting it in the top 41% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Commvault Systems, Inc. (NASDAQ: CVLT) between January 28, 2025 and January 26, 2026, inclusive (the "Class Period"), of the important July 17, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Commvault securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 17, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Commvault's competitive positioning was materially weaker than defendants had represented to investors; (2) due to the undisclosed increase in competition, Commvault was forced to make significant concessions on price and contract duration for its software licenses; (3) as these concessions became unsustainable, Software as a Service ("SaaS") became a larger portion of Commvault's sales mix; (4) in turn, the increasing mix of SaaS sales, which carry shorter term durations and lower average selling prices ("ASPs"), negatively impacted Commvault's margin and Net New ARR ("NNARR"); and (5) as a result, defendants' positive statements about Commvault's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304459
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) -- Hagens Berman, a national shareholder rights firm, alerts investors in Commvault Systems, Inc. (NASDAQ: CVLT) that a newly filed securities class action lawsuit has expanded the alleged class period. The lawsuit now covers investors who purchased or otherwise acquired Commvault securities between January 28, 2025, and January 26, 2026, inclusive.
Hagens Berman is investigating the claims pled in the pending litigation and encourages Commvault investors who suffered substantial losses to submit your losses now.
Expanded Alleged Class Period: Jan. 28, 2025 – Jan. 26, 2026
Lead Plaintiff Deadline: July 17, 2026
Visit: www.hbsslaw.com/investor-fraud/cvlt
Contact the Firm Now: [email protected]
844-916-0895
View our latest video summary of the allegations: www.youtube.com/watch?v=MUMo4d2ZLkI
Expanded Scope of Allegations
The new suit, City of Fort Lauderdale Police and Firefighters' Retirement System v. Commvault Systems, Inc., et al., extends the start of the alleged fraud period from April 29, 2025, back to January 28, 2025. This expansion captures a broader range of investor activity and expands the claims brought against the company and its senior executives regarding their business disclosures.
Focus of CVLT Securities Class Action Litigation:
The litigation alleges that Defendants misrepresented and failed to disclose that:
Commvault’s competitive positioning was materially weaker than Defendants had represented to investors;Due to the undisclosed increase in competition, Commvault was forced to make significant concessions on price and contract duration for its software licenses;As these concessions became unsustainable, SaaS became a larger portion of the Company’s sales mix;The increasing mix of SaaS sales, which carry shorter term durations and lower ASPs, negatively impacted the Company’s margin and NNARR; andAs a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
The truth allegedly emerged before markets opened on January 27, 2026, when Commvault announced its third-quarter fiscal year 20261 financial results. Commvault disclosed NNARR in constant currency of $39 million, missing analysts’ expectations of approximately $45 million. Chief Accounting Officer Danielle Abrahamsen (“CAO Abrahamsen”) revealed that the mix of SaaS deals increased to “70%” during the quarter and highlighted that “landing these customers at a 2 to 3x smaller ASP than software . . . does have a significant impact on ARR.”
On this news, the price of Commvault common stock fell $40.23 per share, or about 31%, to close at a price of $89.13 per share on January 27, 2026.
HBSS Investigation
“We continue to investigate whether Commvault misled investors about its operational performance and financial reporting during the alleged expanded class period, as the new complaint contends” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation of the pending claims.
If you invested in Commvault and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now.
If you’d like more information and answers to frequently asked questions about the Commvault case and the firm’s investigation, read more »
Whistleblowers: Persons with non-public information regarding Commvault should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
San Diego, California--(Newsfile Corp. - July 8, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Commvault Systems, Inc. (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026, inclusive (the "Class Period"), have until Friday, July 17, 2026 to seek appointment as lead plaintiff of the Commvault class action lawsuit. Captioned Imbert v. Commvault Systems, Inc., No. 26-cv-05654 (D.N.J.), the Commvault class action lawsuit charges Commvault and certain of Commvault's current and former executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Commvault class action lawsuit, please provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].
CASE ALLEGATIONS: Commvault provides cyber resiliency solutions for enterprises to protect, secure, and recover data, applications, and identity systems.
The Commvault class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that Commvault's annualized recurring revenue ("ARR") growth would remain steady throughout fiscal year 2026; (ii) Commvault knew or recklessly disregarded the impact that different types of sales would have on its ARR growth; and (iii) the variation in net ARR growth is strongly based on the type of sale Commvault is making, thus, Commvault's projected net new ARR should not have been determined without properly factoring in sale type.
The Commvault class action lawsuit further alleges that on January 27, 2026, Commvault released its third quarter 2026 financial results, revealing net new ARR of $39 million, below Commvault's previously guided $45 million. On this news, the price of Commvault stock fell more than 31%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Commvault securities during the Class Period to seek appointment as lead plaintiff in the Commvault class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Commvault class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Commvault class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Commvault class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Bloom Energy Corporation (“Bloom” or the “Company”) (NYSE: BE) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BLOOM ENERGY CORPORATION (BE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On July 8, 2026, Hunterbrook published a report alleging, among other things, that despite the Company repeatedly claiming Bloom has “no China supply chain” and is “not dependent on China for scandium,” (the rare earth at the core of each Bloom fuel cell) “Bloom is, in fact, reliant on C5 Chinese scandium, according to global trade data, Chinese corporate filings, satellite imagery, and Hunterbrook’s messages with Bloom’s suppliers in China.”
On this news, Bloom’s stock price fell as much as 12% during intraday trading on July 8, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Bloom securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com.
Email us at: [email protected]
Follow us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
FALLING WATERS, W.Va., July 08, 2026 (GLOBE NEWSWIRE) -- LGI Homes proudly announces the grand opening of The Meadows at Riverside, an exciting new single-family home community located in Falling Waters. This highly anticipated neighborhood offers thoughtfully designed homes featuring modern upgrades, spacious layouts and exceptional value in a scenic riverside setting.
The Meadows at Riverside delivers a lifestyle centered on comfort, convenience and outdoor recreation. Nestled among the natural beauty of Falling Waters, residents will enjoy a welcoming community featuring walking paths, pickleball courts, a children’s playground, gazebo, barbecue grills and open green spaces. Outdoor enthusiasts will appreciate the close proximity to Falling Waters Waterfalls Park, the Potomac River and other local parks offering hiking, kayaking, picnicking and year-round recreation.
Centrally located between Martinsburg and Hagerstown, The Meadows at Riverside is a short drive to everyday conveniences. Residents can enjoy a day of shopping at Valley Mall or Crosspoint Shopping Center less than 10 miles from the community. Major commuter routes including I-70, I-81 and US-11, as well as the MARC train station, are also nearby.
"The Meadows at Riverside offers homebuyers an incredible opportunity to enjoy modern living in one of West Virginia's most desirable locations," stated Vice President of Operations Paul DiConsiglio. "With thoughtfully designed homes, included upgrades, outstanding community amenities and a simplified path to homeownership, this community is designed to help families achieve their dream of owning a home."
The community features a collection of spacious three- and four-bedroom single-family homes, each complete with attached two-car garages and flexible floor plans designed to fit a variety of lifestyles. Every home includes LGI Homes' CompleteHome Plus™ package, offering a full suite of upgrades at no additional cost. These enhancements include granite countertops, a tile backsplash, stainless steel Whirlpool® kitchen appliances, designer cabinetry, luxury vinyl plank flooring, Wi-Fi-enabled garage door openers, programmable Honeywell thermostats, energy-efficient features and professionally designed exterior details.
Six thoughtfully designed floor plans are available at The Meadows at Riverside:
Martin – 3 beds, 2 baths, 2-car garage, 1,527 sq. ft.
Allen – 3 beds, 2 baths, 2-car garage, 1,656 sq. ft.
With its upgraded interiors, outstanding amenities, convenient location and welcoming atmosphere, The Meadows at Riverside is poised to become one of the premier new home communities in the Falling Waters area.
A grand opening event will be held on the weekend of July 11 & 12, 2026 with limited-time savings available at the event. Interested buyers are encouraged to contact the LGI Homes Information Center at (833) 788-0974 ext 56 for additional details.
About LGI Homes
Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. LGI Homes has closed over 80,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek’s list of the World’s Most Trustworthy Companies. LGI Homes’ commitment to excellence extends to its more than 1,000 employees, earning the Company numerous workplace awards at the local, state, and national level, including the Top Workplaces USA 2025 Award. For more information about LGI Homes and its unique operating model focused on making the dream of homeownership a reality for families across the nation, please visit the Company’s website at www.lgihomes.com.
MEDIA CONTACT:
Rachel Eaton
(281) 362-8998 ext. 2560
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ed516a97-5363-4205-97d5-386d61f444fa
The Martin by LGI Homes at The Meadows at Riverside The three-bedroom, two-bath Martin features flexible living and open entertainment space.
SANTA ANA, Calif.--(BUSINESS WIRE)--First American Financial Corporation (NYSE: FAF), a premier provider of title, settlement and risk solutions for real estate transactions and the leader in the digital transformation of its industry, today announced that it will host a conference call to discuss its second-quarter 2026 earnings results on Thursday, July 23, 2026, at 11 a.m. EDT.
The call will follow the release of the company’s earnings results for the second quarter of 2026, which is scheduled for Wednesday, July 22, 2026, after the close of regular trading.
The conference call is open to investors, members of the financial community, the media and other members of the public. It can be accessed online at http://www.firstam.com/investor or by dialing toll free 877-407-8293. Callers from outside the United States may dial +1 201-689-8349.
An audio replay of the conference call will be available through August 6, 2026 by dialing 201-612-7415 and using the conference ID 13761705. An audio archive of the call and a copy of the second-quarter 2026 earnings release, including the financial information contained therein, will also be available on First American’s investor website.
At the present time, the company expects to issue a news release announcing its third-quarter financial results after the close of regular trading on Wednesday, Oct. 21, 2026 and host a conference call at 11 a.m. EDT on Thursday, Oct. 22, 2026.
About First American
First American Financial Corporation (NYSE: FAF) is a premier provider of title, settlement, and risk solutions for real estate transactions. With its combination of financial strength and stability built over more than 135 years, innovative proprietary technologies, and unmatched data assets, the company is leading the digital transformation of its industry. First American also provides data products to the title industry and other third parties; valuation products and services; mortgage subservicing; home warranty products; banking, trust and wealth management services; and other related products and services. With total revenue of $7.5 billion in 2025, the company offers its products and services directly and through its agents throughout the United States and abroad. In 2026, First American was named one of the 100 Best Companies to Work For by Great Place to Work® and Fortune Magazine for the eleventh consecutive year. More information about the company can be found at www.firstam.com.
More News From First American Financial Corporation
, /PRNewswire/ -- Rollins, Inc. (NYSE: ROL), a premier global consumer and commercial services company, today announced that it will release its second quarter results for the period ended June 30, 2026, after the market closes on Wednesday, July 22, 2026. In conjunction with its release, the Company will host a conference call to review the Company's financial and operating results before the market opens on Thursday, July 23, 2026, at 8:30 a.m. Eastern Time.
Individuals wishing to participate in the conference call should call 1-877-869-3839 (domestic) or +1-201-689-8265 (internationally) with conference ID 13761216. The conference call will also be broadcast live over the internet and can be accessed by all interested parties via a link provided on the Rollins, Inc. website at www.rollins.com/investors/events-presentations. For interested individuals unable to join the call, a replay will be available on the website for 180 days.
About Rollins, Inc.
Rollins, Inc. (ROL) is a premier global consumer and commercial services company. Through its family of leading brands, the Company and its franchises provide essential pest control services and protection against termite damage, rodents, and insects to more than 2.8 million customers in North America, South America, Europe, Asia, Africa, and Australia, with approximately 22,000 employees from more than 850 locations. Rollins is parent to Aardwolf Pestkare, Clark Pest Control, Crane Pest Control, Critter Control, Fox Pest Control, HomeTeam Pest Defense, Industrial Fumigant Company, MissQuito, Northwest Exterminating, OPC Pest Services, Orkin, Orkin Australia, Orkin Canada, Orkin UK, Safeguard, Romex Pest Control, Saela Pest Control, Trutech, Waltham Services, Western Pest Services, and more. You can learn more about Rollins and its subsidiaries by visiting www.rollins.com.
For Further Information Contact
Lyndsey Burton
(404) 888-2348
, /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced that it expects to release second quarter 2026 results after the market closes on Thursday, July 16, 2026. The earnings release and accompanying earnings presentation will be available on the company's website at www.cohenandsteers.com under "Company—Investor Relations—Earnings Archive."
The company will host a conference call on Friday, July 17, 2026 at 10:00 a.m. (ET) with access available via webcast and telephone. Chief Executive Officer, Joseph Harvey, Chief Financial Officer, Amit Muni, and President and Chief Investment Officer, Jon Cheigh, will review the company's operating results and outlook and be available for questions.
Investors and analysts can access the live conference call by dialing 800-715-9871 (U.S.) or +1-646-307-1963 (international); passcode: 8494569. Participants should plan to register at least 10 minutes before the conference call begins. A replay of the call will be available for two weeks starting approximately two hours after the conference call concludes and can be accessed at 800-770-2030 (U.S.) or +1-609-800-9909 (international); passcode: 8494569. Internet access to the webcast, which includes audio (listen-only), will be available on the company's website at www.cohenandsteers.com under "Company—Investor Relations" under "Financials." The webcast will be archived on the website for one month.
About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.
Contact:
Brian Meta
Senior Vice President
Head of Investor Relations and FP&A
Tel (212) 796-9353
Broadcom (NASDAQ:AVGO | AVGO Price Prediction) and Marvell Technology (NASDAQ:MRVL) both sell custom AI silicon and networking chips to hyperscalers. Broadcom trades near $370, roughly 25% below its 52-week high after a Google diversification scare. Marvell has quietly tripled off spring lows. The businesses tell very different stories.
Broadcom Posts Records While Marvell Reaccelerates Broadcom’s Q2 FY2026 landed at $22.19 billion in revenue, up 47.9% year over year, with AI semiconductor revenue of $10.80 billion, up 143%. Free cash flow ran at 46% of revenue, remarkable at this scale. CEO Hock Tan told investors that “the momentum continues and in Q3 we expect semiconductor revenue from AI to grow over 200 percent year-over-year to $16.0 billion.” That is a step function.
Marvell delivered $2.42 billion in revenue, up 27.6%, with the data center segment doing $1.83 billion, or 76% of the total. Matt Murphy called out “exceptional AI-related bookings” and guided Q2 to $2.70 billion, roughly 35% growth.
Business Driver Broadcom Marvell Main Growth Engine Custom XPUs, Ethernet AI networking 800G/1.6T optics, custom XPU-attach AI Revenue (Latest Q) $10.8B $1.83B data center Adjacent Business VMware software ($7.18B) Post-auto-ethernet pure play Cash Machine Versus Comeback Story Broadcom monetizes scale with 67% non-GAAP operating margins guided into Q3 and multi-year custom-silicon commitments from Meta, Anthropic, and OpenAI, including the co-developed “Jalapeño” inference chip. Marvell is reshaping itself: it sold automotive ethernet to Infineon for $2.5 billion, then bought Celestial AI for photonic fabric and XConn for chiplet connectivity, and raised $2.0 billion in convertible preferred to fund the pivot.
Capital return follows the same logic. Broadcom runs a $10 billion buyback and pays a $0.65 quarterly dividend. Marvell repurchased $200 million and pays a token $0.06.
Customer Concentration Is the Real Test The bear case on Broadcom is that Google could shift some custom TPU volume toward cheaper designers like MediaTek. That fear carved the 25% discount off the $494.18 52-week high. Keep an eye on Q3 AI revenue landing at or above $16 billion, and on Marvell’s next data center earnings report, where the 800G to 1.6T optics ramp must show through.
Why Broadcom Looks Better at This Price You are paying a forward P/E near 19 for a business compounding AI revenue triple digits with 46% free-cash margins and named commitments from Meta, Anthropic, and OpenAI. Marvell’s optical scale-up thesis is compelling, but at a forward P/E near 61 and after a 171% year-to-date run, you are underwriting significant upside. If custom silicon consolidates around fewer designers, Broadcom’s incumbency looks structural. If Google splits its TPU work three ways, I will revisit.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Broadcom didn't make the cut. Grab the names FREE today.
DALLAS--(BUSINESS WIRE)--Copart, Inc. (NASDAQ: CPRT) today announced that Jane Pocock has been promoted to President of Copart, effective August 1, 2026.
Ms. Pocock joined Copart in January 2019 as Managing Director of Copart UK and has led one of the Company’s key international businesses through a period of significant growth and expansion. Under her leadership, Copart UK and Ireland has strengthened its operational footprint, expanded capacity, and delivered exceptional customer journeys for insurance carriers and their policyholders, commercial sellers, and Copart members. In her new role, Ms. Pocock brings proven experience pairing operational execution with technology-enabled products and services that help customers achieve better outcomes, while continuing to support the strong teams and customer relationships that have driven Copart’s success in the UK and Ireland.
Ms. Pocock has paired significant growth with thoughtful, people-oriented leadership. She has helped differentiate Copart’s customer experience through technology, service quality, and strong team execution. Her promotion reflects the Company’s confidence in the UK and Ireland business and its leadership team, as well as the opportunity to extend those strengths across Copart’s global platform. Prior to joining Copart, Ms. Pocock was Chief Executive of Vans Direct.
“Jane has delivered outstanding results while building strong teams and strengthening our culture,” said Jay Adair, Executive Chairman and incoming Chief Executive Officer of Copart. “For our insurance customers and their policyholders, commercial sellers, and members, Jane brings immediate experience leading customer-focused growth at scale. Her promotion reflects both the strength of our UK and Ireland business and the opportunity to extend that proven leadership across Copart globally. We look forward to her contributions as President of Copart.”
“I am honored to serve as President of Copart,” said Ms. Pocock. “Copart’s success has always been driven by its people, its technology, and its relentless commitment to customers and members. I am proud of what our UK and Ireland teammates have accomplished, and I look forward to continuing to support that momentum while working with our teams around the world to grow, strengthen our differentiated products and services, and deliver exceptional customer experiences globally.”
About Copart
Copart, Inc., founded in 1982, is a global leader in online vehicle auctions. Copart’s innovative technology and online auction platforms connect vehicle consignors to approximately 1 million members in over 185 countries. Copart offers a comprehensive suite of vehicle remarketing services to insurance companies, financial institutions, dealers, rental car companies, charities, fleet operators, and individuals, and offers vehicles via auction to dealers, dismantlers, rebuilders, exporters, and the general public. With operations at over 250 locations in 11 countries, Copart sold more than 4 million units in the last year. Copart currently operates in the United States (Copart.com), Canada (Copart.ca), the United Kingdom (Copart.co.uk), Brazil (Copart.com.br), the Republic of Ireland (Copart.ie), Germany (Copart.de), Finland (Copart.fi), the United Arab Emirates, Oman and Bahrain (Copartmea.com), and Spain (Copart.es). For more information, or to become a Member, visit Copart.com/register.
Cautionary Note About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws. These forward-looking statements are subject to substantial risks and uncertainties. These forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected or implied by our statements and comments. For a more complete discussion of the risks that could affect our business, please review the “Management’s Discussion and Analysis” and the other risks identified in Copart’s latest Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, as filed with the Securities and Exchange Commission. We encourage investors to review these disclosures carefully. We do not undertake to update any forward-looking statement that may be made from time to time on our behalf.
ST. LOUIS, July 08, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”) today announced that Michael Axelrod has been appointed as the company's next President and Chief Executive Officer, effective July 29, 2026. He will also be appointed to the Company's Board of Directors. Darcy Davenport, who announced her intention to retire from the Company earlier this year, will serve in a senior advisory capacity to support a seamless leadership transition and provide strategic support.
ST. LOUIS, July 08, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) today announced it will release its financial results for the third quarter of fiscal year 2026 and its fiscal year 2026 outlook on August 4, 2026, at 7:00 a.m. ET. The release will be followed by a conference call at 8:30 a.m. ET to discuss the results and outlook. Michael C. Axelrod, announced today as the Company’s next President and Chief Executive Officer effective July 29, 2026, and Paul A. Rode, Chief Financial Officer, will participate in the call.
Interested parties may join the conference call by registering in advance at the following link: BellRing Q3 2026 Earnings Conference Call. Upon registration, participants will receive a dial-in number and a unique passcode to access the conference call. Interested parties are invited to listen to the webcast of the conference call, which can be accessed by visiting the Investor Relations section of BellRing’s website at www.bellring.com. A webcast replay also will be available for a limited period on BellRing’s website in the Investor Relations section.
About BellRing Brands, Inc.
BellRing Brands, Inc. (NYSE: BRBR) is a dynamic and fast-growing consumer brands business with the purpose of Changing Lives with Good Energy. Focused on growing the proactive wellness category, the company’s brands include Premier Protein, the #1 ready-to-drink protein and proactive wellness brand, and Dymatize, the brand behind the #1 hydrolyzed protein powder. A culture-driven, pure-play company, BellRing Brands believes nutrition is at the core of a healthy world and produces products with best-in-class nutritional profiles and exceptional flavors. Its products are distributed in over 90 countries across club, mass, food, eCommerce, specialty, drug and convenience. To learn more visit www.bellring.com.
Contact:
Investor Relations
Jennifer Meyer [email protected]
(415) 814-9388
, /PRNewswire/ -- Huntington Bancshares Incorporated (Nasdaq: HBAN) will release second quarter 2026 financial results prior to the market opening on Thursday, July 23, 2026. A news release and supporting financial data will be available at that time on the Investor Relations section of the Company's website (www.huntington-ir.com).
The Company will host a conference call to review quarterly financial results at 9 a.m. ET.
Webcast Information
The second quarter 2026 earnings conference call, along with slides, may be accessed via a live Internet webcast in the Investor Relations section of Huntington's website or through a dial-in telephone number at (877) 407-8029 or (201) 689-8029; conference ID # 13761371.
A replay of the webcast will be archived in the Investor Relations section of Huntington's website. A telephone replay will be available approximately three hours after the completion of the call through Friday, July 31, 2026, at (877) 660-6853 or (201) 612-7415; conference ID # 13761371.
About Huntington
Huntington Bancshares Incorporated is a $285 billion asset regional bank holding company headquartered in Columbus, Ohio. Founded in 1866, The Huntington National Bank and its affiliates provide consumers, small and middle-market businesses, corporations, municipalities, and other organizations with a comprehensive suite of banking, payments, wealth management, and risk management products and services. Huntington operates over 1,400 branches in 21 states, with certain businesses operating in extended geographies. Visit Huntington.com for more information.
CarMax's (KMX 1.41%) summer started off well, with impressive stock performance despite a quarterly earnings report that, at least initially, wasn't well received. After analysts piled in with a clutch of price target raises and even a recommendation upgrade, the vehicle retailer's stock started heading north again. A series of insider buys also lifted confidence in the stock, and it exited June up by almost 19%.
Stop and start That earnings release was published on June 17, and, at least outwardly, CarMax did well against expectations. Net revenue was just over $8 billion in its first quarter of fiscal 2027, for a year-over-year gain of 6%. Net income under generally accepted accounting principles (GAAP) fell by 12%, however, to $186 million, or $1.31 per share.
Image source: Getty Images.
Despite the bottom-line decline, both metrics handily beat the consensus analyst estimates. On average, pundits tracking the auto retailer's stock were modeling revenue of less than $7.4 billion and GAAP net income of only $0.96 per share.
CarMax was a victim of timing, to an extent. As encouraging as some of the retailer's metrics were, they came at a time of persistently high gasoline prices, driven mostly by this country's conflict with Iran. Most of the models sold by the company are gas-consuming internal combustion engine (ICE) ones.
Also in mid-June, speculation grew that the U.S. Federal Reserve would raise interest rates; if that occurs, auto loans will become more expensive and will likely negatively affect the car market (and, more directly, squeeze the company's proprietary lending arm, CarMax Auto Finance).
Yet the reactions of analysts tracking CarMax stock were in stark contrast to those of investors selling their shares after the quarterly results were published. A clutch of them raised their price targets on CarMax, with one, Jeff Lick of Stephens, going so far as to upshift his recommendation on the stock. For him, it's now an overweight (read: buy), one notch up from his previous equalweight (hold). He also substantially raised his price target to $66 per share from the preceding $43.
Today's Change
(
-1.41
%) $
-0.72
Current Price
$
50.33
The inside scoop The bullishness in the stock stemming from those analyst moves was exacerbated by a series of insider stock purchases. The most notable buyer was CEO Keith Barr, who purchased 9,400 CarMax shares on June 22. Four members of the company's board of directors also opened their wallets for this purchase, collectively snapping up 14,674 shares.
I feel the immediate sell-off was unjustified; even if profitability declined, that sales growth figure was encouraging, and management seems to be implementing its new "four pillar" business strategy well. The only major concern I would have is gas prices; if they stay lofty, I'd worry that the mega-dealership could take some hits.
SAN JOSE, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- QuantumScape Corporation (NASDAQ: QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced it will release its 2026 second-quarter business results after market close on Wednesday, July 22, 2026. This will be followed by a conference call at 2 p.m. Pacific Time (5 p.m. Eastern Time). Siva Sivaram, chief executive officer, and Kevin Hettrich, chief financial officer, will participate on the call.
Starting today, July 8, shareholders can submit questions (here) they would like addressed on the call. QuantumScape management will respond to a selection of the submitted questions. The company will accept questions until Tuesday, July 21, at 2 p.m. Pacific Time (5 p.m. Eastern Time).
The call will be accessible live via a webcast on QuantumScape’s IR Events Calendar page. An archive of the webcast will be available shortly after the call for 12 months.
About QuantumScape Corporation
QuantumScape is on a mission to revolutionize energy storage to enable a sustainable future. The company’s next-generation batteries are designed to enable greater energy density, faster charging and enhanced safety to support the transition away from legacy energy sources toward a lower carbon future. For more information, visit www.quantumscape.com.
NORTH ANDOVER, Mass.--(BUSINESS WIRE)--Watts Water Technologies, Inc. (NYSE: WTS) will report its financial results for the second quarter 2026 in a press release to be issued after market close on Wednesday, August 5, 2026, and has scheduled a conference call and webcast on Thursday, August 6, 2026, at 9:00 a.m. Eastern Standard Time to discuss the results and outlook.
This call can be accessed by visiting the Investor Relations section of the Company’s website at www.watts.com. Following the webcast, an archived version of the call will be available at the same address until August 5, 2027.
Watts is pleased to announce that Ray Nash has joined the company as Vice President, Investor Relations and FP&A. He will join Robert J. Pagano, Jr., President and CEO, and Diane McClintock, CFO, on the earnings call.
Watts Water Technologies, Inc., through its family of companies, is a global manufacturer headquartered in the USA that provides one of the broadest plumbing, heating, and water quality product lines in the world. Watts Water companies and brands offer innovative plumbing, heating, and water quality solutions to control the efficiency, safety, and quality of water within commercial, residential, and industrial applications. For more information visit www.watts.com.
Should you stick with a diversified healthcare titan or a specialized high-growth challenger? Here is how Abbott Laboratories (ABT 0.70%) and Glaukos (GKOS +1.53%) stack up for investors looking ahead into 2026.
Abbott operates as a global leader across diagnostics, nutrition, and medical devices, offering stability through its massive scale. Glaukos focuses on ophthalmic solutions, aiming to disrupt the way doctors treat glaucoma and corneal diseases. Both compete for space among medical device stocks but offer very different risk and reward profiles.
The case for Abbott LaboratoriesAbbott is a diversified healthcare leader selling medical devices, diagnostic tools, nutritional products, and generic medicines. Its portfolio includes high-growth areas like diabetes care and cardiovascular solutions. As of March 2026, the company expanded its presence in oncology by acquiring Exact Sciences for $23 billion. This acquisition integrated new cancer diagnostics technology into the existing Diagnostic Products segment. Abbott does not rely on any single customer for a material portion of its revenue, which helps reduce the risk of a sudden loss of business.
In FY 2025, revenue reached $44.3 billion, representing growth of roughly 5.5% compared to the previous year. The company reported net income of close to $6.5 billion for the same period. This resulted in a net margin of 14.7%. While revenue has grown steadily, this net margin was lower than the 31.9% recorded in 2024, reflecting the costs associated with its large-scale business shifts and recent acquisitions.
Its current, the debt-to-equity ratio is approximately 0.65x. This ratio measures total debt relative to shareholders’ equity, with lower ratios indicating less reliance on borrowed money. Free cash flow, which is the cash left after paying for capital expenditures, was nearly $7.4 billion for the fiscal 2025.
The case for GlaukosGlaukos is a specialist in the ophthalmic medical technology market, focusing on therapies for glaucoma and retinal diseases. The company generates revenue primarily from ophthalmic surgeons and surgical centers rather than a few large distributors. No single customer accounts for more than 10% of total net sales. While it operates globally, roughly 75% of its 2025 sales came from the United States. The company is betting heavily on its iStent and iDose platforms to capture a larger share of the vision care market.
For FY 2025, Glaukos reported revenue of $507.4 million, representing a 32% year-over-year increase. Despite this rapid top-line expansion, the company reported a net loss of approximately $187.7 million The company continues to prioritize growth and research over immediate profitability.
The current debt-to-equity ratio was roughly 0.16x. Free cash flow was negative at approximately $22.5 million, as the company spent more on operations and capital investments than it generated in cash.
Risk profile comparisonAbbott faces persistent legal exposure, including securities class actions regarding FDA compliance failures. It also deals with civil litigation related to infant formula facilities and product liability lawsuits involving spinal cord stimulators. Integrating the $23 billion Exact Sciences acquisition adds operational complexity and increased debt. Furthermore, the company must invest heavily in cybersecurity following previous data breaches to protect its sensitive customer information.
Glaukos relies heavily on its San Clemente, California, campus to manufacture its main product lines. Any disruption at this single location could severely impair its ability to supply customers. The company also depends on reimbursement levels from Medicare and private payers, making it vulnerable to changes in government coding or payment rates. Finally, Glaukos faces stiff competition from much larger and better-capitalized firms such as AbbVie (ABBV 0.75%) and Alcon Inc (ALC 0.46%).
Valuation comparisonAbbott looks significantly cheaper on a Forward P/E basis, while Glaukos maintains a much higher P/S ratio as investors price in its rapid growth potential.
MetricAbbott LaboratoriesGlaukosSector BenchmarkForward P/E17.4x2,000x389.1xP/S ratio3.7x15.5xSector benchmark uses the SPDR XLV sector ETF.
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Abbott Labs's recent quarterly results and its guidance for fiscal 2026 presented investors with a mixed bag. The Medical Device segment, led by cardiovascular devices, brought solid growth, but Abbott is seeing a slowdown in new users for its glucose monitoring system FreeStyle Libre CGM. The Nutrition business continues to show weakness as Abbott discounts prices to increase volume.
Abbott’s strengths are that Exact Sciences adds a cancer screening arm, and folds in the popular Cologuard product to its portfolio. Abbott should be able to power sales outside the U.S. for Cologuard. For 2026, Abbott should get company-wide sales over $50 billion, which would be about 13% year-over-year growth.
Glaukos has been pioneering treatment for glaucoma and other eye disorders, developing micro-invasive glaucoma surgery (MIGS) early in this decade. MIGS is now a standard globally. Investors are especially excited about a new product that just came to market this year called Epioxa. It’s an incision-free alternative to treating keratoconus, a rare, sight-threatening disease. The potential is huge—by 2030, Glaukos believes it could be used on 18,000 eyes, bringing in more than $1 billion in revenue.
For 2026, iDose continues to power the business with excellent U.S. growth. Analysts see sales rising almost 25% to $630 million, with a narrowing of the net loss to about $56 million.
The choice here is between a health care giant hoping to buy its way to growth and a diagnostic startup that has revolutionized one area of treatment and looks set to do the same for a second. Glaukos comes at a premium. But its fast growth means long-term investors should be getting good value in the long run.
Well-Positioned to Continue Leading Innovation, Capturing Growth and Executing with Excellence.
ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) today hosted its 2026 Investor Day during which AV’s leadership team outlined its growth strategy and introduced new fiscal year 2030 financial targets.
“At AV, we are driving the business forward as a stronger, more resilient company than ever,” said Wahid Nawabi, Chairman, President and Chief Executive Officer at AV. “We look forward to leading product innovation, scaling our capacity to capture demand across multiple domains, and continuing to execute with excellence for the remainder of the decade. Two years ago, we outlined an ambitious set of strategic objectives designed to accelerate growth and we’ve delivered on several of these initiatives, giving us momentum for the road ahead. We will leverage AV's proven business model to commercialize new technologies across a broader global and commercial customer base. The fiscal year 2030 financial targets we provided today underscore our confidence in our ability to create long-term value for our shareholders.”
AV introduced fiscal year 2030 financial targets and expects to achieve:
$3.5 - $4.0 billion in revenue, a 15% - 20% organic CAGR, driven by market expansion and leadership 7% - 9% investment in R&D to accelerate innovation and keep AV ahead of competition 18% - 20% adjusted EBITDA margins driven by operational excellence and sustainable profitability A webcast replay and presentation used in today’s event are available on the Investor Relations section of www.avinc.com.
ABOUT AEROVIRONMENT, INC.
AeroVironment (“AV”) (NASDAQ: AVAV) is a defense technology leader delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities—built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities with speed, scale, and operational relevance.
For more information visit: www.avinc.com.
SAFE HARBOR STATEMENT
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as “will,” “believe,” “anticipate,” “expect,” “estimate,” “intend,” “project,” “plan,” or words or phrases with similar meaning. Forward-looking statements are based on current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors outside of our control, that may cause our business, strategy or actual results to differ materially from the forward-looking statements.
Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the impact of our ability to successfully close and integrate acquisitions into our operations and avoid disruptions from acquisition transactions that will harm our business; the recording of goodwill and other intangible assets as part of acquisitions that are subject to potential impairments in the future and any realization of such impairments; any actual or threatened disruptions to our relationships with our distributors, suppliers, customers and employees, including shortages in components for our products, whether due to restrictions and sanctions imposed by foreign governments or otherwise; the ability to timely and sufficiently integrate international operations into our ongoing business and compliance programs; reliance on sales to the U.S. government, including uncertainties in classification, pricing or potentially burdensome imposed terms for certain types of government contracts; availability of U.S. government funding for defense procurement and R&D programs; our ability to win U.S. and international government R&D and procurement programs, including foreign military financing aid; changes in the timing and/or amount of government spending, including due to continuing resolutions and/or changing government priorities; adverse impacts of any U.S. government shutdown; our ability to realize the anticipated benefits of the BlueHalo transaction or other acquisitions; our ability to execute contracts for anticipated sales, perform under such contracts and other existing contracts and obtain new contracts; risks related to our international business, including compliance with export control laws; the extensive and increasing regulatory requirements governing our contracts with the U.S. government and international customers; the consequences to our financial position, business and reputation that could result from failing to comply with applicable law, regulatory requirements, and contractual obligations; unexpected technical and marketing difficulties inherent in major research and product development efforts; the impact of potential security and cyber threats or the risk of unauthorized access to and resulting misuse of our, our customers’ and/or our suppliers’ information and systems; failure to remain a market innovator, to create new market opportunities or to expand into new markets; our ability to increase production capacity to support anticipated growth; unexpected changes in significant operating expenses, including components and raw materials; failure to develop new products or integrate new technology into current products; any increase in litigation activity or unfavorable results in legal proceedings, including pending class actions, or litigation that may arise from or in conjunction with our recent acquisitions; our ability to respond and adapt to legal, regulatory and government budgetary changes; our ability to comply with the covenants in our loan documents, outstanding convertible notes or acquisition and merger agreements for acquisitions; our ability to attract and retain skilled employees, including retention of employees of acquired companies; the impact of inflation; and general economic and business conditions in the United States and elsewhere in the world; and the failure to establish and maintain effective internal control over financial reporting. For a further list and description of such risks and uncertainties, see the reports we file with the Securities and Exchange Commission. We do not intend, and undertake no obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
